Re:Operation Warp Speed: A new model for industrial policy
by yzmtf2008 on Sunday January 30, 2022 @05:44PM
(#30142017)
> As far as I'm aware, no existing facilities were added?
Nowhere in your linked article indicates that "no existing facilities were added".
> As of January 2022, the Pfizer-BioNTech COVID-19 vaccine is manufactured between 11 sites across five countries, including the U.S., Germany, Belgium, Ireland, and Croatia, and engages more than 20 suppliers.
https://www.pfizer.com/science/coronavirus/vaccine/manufactu...
Re:Operation Warp Speed: A new model for industrial policy
by NicoJuicy on Sunday January 30, 2022 @05:50PM
(#30142070)
I'm from Belgium and i did follow up on Puurs and i hadn't encountered any news that they needed to upgrade facilities there.
That's what you should have copied my whole sentence: "as far as I'm aware, no existing facilities were added". Which in retrospect should be upgraded actually. Didn't notice that mistake.
Re:Operation Warp Speed: A new model for industrial policy
by b3orn on Sunday January 30, 2022 @06:00PM
(#30142151)
Biontech bought production facilities in Germany.
Re:Operation Warp Speed: A new model for industrial policy
by NicoJuicy on Sunday January 30, 2022 @06:04PM
(#30142184)
Yeah, seems to be correct.
https://www.brusselstimes.com/131709/biontech-buys-a-novarti...
But i did mention the facility in Puurs ( since it's from my country), i wasn't keeping track on all of them ofc
As far as I'm aware, no existing facilities were upgraded/expanded? https://www.politico.eu/article/belgium-town-puurs-spotlight...
A big up for Belgian pharma facilities. But I'm unsure about the role of operation Warp speed on this all.
As far as I'm aware, Pfizer/BionTech explicitly avoided any funding through operation Warp Speed. They received an order in phase 3 of the clinical trials.
The core issue ( why they partnered with Pfizer) for BionTech was also not production at scale, but handling clinical trials at this scale. Which ( again/also) was not related to Warp Speed.